Prior studies in hepatocellular and breast cancers show that IGF2BP3 (IMP3) binds the 3′ UTR of SREBP1c mRNA, stabilizing the transcript and enhancing SREBP1c nuclear accumulation and transactivation of lipogenic targets, including FASN [36,37]. This evidence concerns the gene IGF2BP3 and breast carcinoma.